Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021207303 - IMMUNE STIMULATION AGAINST CORONAVIRUS INFECTIONS

Publication Number WO/2021/207303
Publication Date 14.10.2021
International Application No. PCT/US2021/026103
International Filing Date 07.04.2021
IPC
A61K 31/739 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
739Lipopolysaccharides
A61K 39/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
A61K 39/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
CPC
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C12N 2770/20034
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
20011Coronaviridae
20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applicants
  • ALSATECH, INC. [US]/[US]
Inventors
  • NICOLAU, Claude
  • THINARD, Reynald
  • GREFERATH, Ruth
  • CHEVALIER, Melanie
Agents
  • ALTIERI, Stephen, L.
  • FRANK, Steven, J.
  • CURRIE, Matthew, T.
  • LIN, Yi-chia
  • HAYMAN, Mark, L.
Priority Data
63/006,40107.04.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) IMMUNE STIMULATION AGAINST CORONAVIRUS INFECTIONS
(FR) STIMULATION IMMUNITAIRE CONTRE DES INFECTIONS À CORONAVIRUS
Abstract
(EN) The present invention is related to methods and compositions for the therapeutic and diagnostic use in the treatment of infections that are caused by or associated with coronaviruses (e.g., SARS-CoV-2). In particular, the present invention provides novel methods and compositions for eliciting a highly specific and highly effective immune response in a patient, which is capable of preventing or alleviating coronavirus infections, or symptoms associated with coronavirus infections, including the novel SARS-CoV-2 infection, COVID-19.
(FR) La présente invention concerne des procédés et des compositions destinés à une utilisation thérapeutique et diagnostique dans le traitement d'infections qui sont provoquées par des coronavirus (par exemple, SARS-CoV-2) ou associées à ceux-ci. En particulier, la présente invention concerne de nouveaux procédés et de nouvelles compositions pour déclencher une réponse immunitaire hautement spécifique et hautement efficace chez un patient, qui est capable de prévenir ou d'atténuer des infections à coronavirus, ou des symptômes associés à des infections à coronavirus, y compris la nouvelle infection par le SARS-CoV-2, la COVID-19.
Latest bibliographic data on file with the International Bureau